GW Pharmaceuticals closes £19mm private placement
GW Pharmaceuticals PLC (develops pharmaceuticals that are derived from cannabis) netted £19mm ($31.5mm) through the sale of 9.9mm ordinary shares at £2 each ($3.30; a 13% discount to the market average price) to existing and new investors.
- Private Investment in Public Equity
- Private Placement
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com